Načítá se...
Will neo-adjuvant immunotherapy become a new paradigm in the treatment of lung cancer patients
Nowadays neoadjuvant immunotherapy is one of the main research areas in oncology. This interest is supported by the success of check-point inhibitors in treatment of advanced and metastatic lung cancer. The postulate that neoadjuvant immunotherapy achieves tumor devitalization before surgery is conf...
Uloženo v:
Hlavní autoři: | , , , , , , , |
---|---|
Médium: | Artigo |
Jazyk: | Russo |
Vydáno: |
Remedium Group LLC
2019-12-01
|
Edice: | Медицинский совет |
Témata: | |
On-line přístup: | https://www.med-sovet.pro/jour/article/view/5047 |
Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|